Dalal Street Hot Chips Buy Calls: JUBILANT ORGANOSYS
JUBILANT ORGANOSYS
BSE Code: 530019
CMP: 320.20
Investment: Short to Medium Term
The industry leaders in the have presented their wish lists to the Ministry of Finance. With the previous budget being neutral on the pharmaceutical industry, there is a buzz that the ministry may have something to offer in this budget. There is, in fact, strong speculation that the 150 per cent weighted deduction enjoyed by in-house R&D expenses should be extended to expenses on outsourced studies such as clinical trials and specific laboratory studies. There is also a demand that the weighted deduction should be raised to 200 per cent. This move, if approved, is likely to have a very positive impact on the CRAMS (Contract Research and Manufacturing Services) players. Jubilant Organosys being the largest CRAMS player may derive benefit from such a move. Therefore, investors can look at this stock from a short to medium-term perspective.
*To get the password for buy calls, please subscribe to this blog. You will receive the password in next email to you*If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
No comments yet.
Leave a comment